{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:20:49Z","timestamp":1794313249230,"version":"4.9.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1097\/tp.0000000000001589","type":"journal-article","created":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T09:04:30Z","timestamp":1481360670000},"page":"2582-2589","source":"Crossref","is-referenced-by-count":32,"title":["Belatacept Compared With Tacrolimus for Kidney Transplantation"],"prefix":"10.1097","volume":"101","author":[{"given":"Jordana B.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Eddinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Forde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Abt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Sawinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-47-20210211","doi-asserted-by":"crossref","first-page":"409","DOI":"10.5414\/CNP57409","article-title":"Hypertension in renal transplantation: donor and recipient risk factors","volume":"57","author":"Ducloux","year":"2002","journal-title":"Clin Nephrol"},{"key":"R2-47-20210211","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"R3-47-20210211","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ajhp\/61.6.565","article-title":"Drug-related dyslipidemia after renal transplantation","volume":"61","author":"Mathis","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"R5-47-20210211","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"R7-47-20210211","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1600-6143.2011.03914.x","article-title":"Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys","volume":"12","author":"Pestana","year":"2012","journal-title":"Am J Transplant"},{"key":"R8-47-20210211","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"R9-47-20210211","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"R10-47-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.13195","article-title":"OPTN\/SRTR 2013 Annual Data Report: kidney","volume":"15","author":"Matas","year":"2015","journal-title":"Am J Transplant"},{"key":"R11-47-20210211","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-6143.2010.03338.x","article-title":"Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients","volume":"11","author":"Ferguson","year":"2011","journal-title":"Am J Transplant"},{"key":"R12-47-20210211","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.13853","article-title":"Comparison of utilization and clinical outcomes for belatacept- and tacrolimus-based immunosuppression in renal transplant recipients","volume":"16","author":"Wen","year":"2016","journal-title":"Am J Transplant"},{"key":"R13-47-20210211","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/TP.0b013e3181ac620b","article-title":"A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index","volume":"88","author":"Rao","year":"2009","journal-title":"Transplantation"},{"key":"R15-47-20210211","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/TP.0b013e3182a688e5","article-title":"Predictors of graft failure and death in elderly kidney transplant recipients","volume":"96","author":"Faravardeh","year":"2013","journal-title":"Transplantation"},{"key":"R16-47-20210211","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ctr.12294","article-title":"Long-term outcomes in African American kidney transplant recipients under contemporary immunosuppression: a four-yr analysis of the Mycophenolic acid Observational REnal transplant (MORE) study","volume":"28","author":"Narayanan","year":"2014","journal-title":"Clin Transplant"},{"key":"R17-47-20210211","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1536867X0400400307","article-title":"Implementing matching estimators for average treatment effects in Stata","volume":"4","author":"Abadie","year":"2004","journal-title":"Stata Journal"},{"key":"R18-47-20210211","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/pds.969","article-title":"Principles for modeling propensity scores in medical research: a systematic literature review","volume":"13","author":"Weitzen","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-47-20210211","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"R20-47-20210211","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/sim.5705","article-title":"The performance of different propensity score methods for estimating marginal hazard ratios","volume":"32","author":"Austin","year":"2013","journal-title":"Stat Med"},{"key":"R21-47-20210211","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox Proportional Hazards Model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"R23-47-20210211","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2215\/CJN.11741115","article-title":"Creatinine-based and cystatin C-based GFR estimating equations and their non-GFR determinants in kidney transplant recipients","volume":"11","author":"Keddis","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R24-47-20210211","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/tri.12605","article-title":"Does belatacept improve outcomes for kidney transplant recipients? A systematic review","volume":"28","author":"Talawila","year":"2015","journal-title":"Transpl Int"},{"key":"R25-47-20210211","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1185\/03007995.2016.1157463","article-title":"Indirect treatment comparison of belatacept versus tacrolimus from a systematic review of immunosuppressive therapies for kidney transplant patients","volume":"32","author":"Muduma","year":"2016","journal-title":"Curr Med Res Opin"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:26:59Z","timestamp":1620977219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201710000-00047"}},"subtitle":["A Propensity Score Matched Cohort Study"],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001589","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}